Search alternatives:
significantly reported » significantly related (Expand Search), significantly restored (Expand Search), significantly predicted (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
time decrease » time increased (Expand Search), sizes decrease (Expand Search), teer decrease (Expand Search)
Showing 81 - 100 results of 30,263 for search '(( significant ((time decrease) OR (greater decrease)) ) OR ( significantly reported decrease ))', query time: 0.98s Refine Results
  1. 81
    Minimal dataset for tumor volume and body weight.

    Minimal dataset for tumor volume and body weight. by Yoshiaki Tadokoro (16851585)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 82
    Minimal dataset for immunohistochemical evaluation, IRS score.

    Minimal dataset for immunohistochemical evaluation, IRS score. by Yoshiaki Tadokoro (16851585)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 83
    Tumor volume and body weight of mice in control and CO<sub>2</sub>-treated groups.

    Tumor volume and body weight of mice in control and CO<sub>2</sub>-treated groups. by Yoshiaki Tadokoro (16851585)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 84
    Relationship between axial strain and time curve.

    Relationship between axial strain and time curve. by Dengke Yang (842532)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 85
    Key CHWs’ performance indicators by focus and time period.

    Key CHWs’ performance indicators by focus and time period. by Nicole Michelén Ströfer (19269154)

    Published 2024
    Save to List
    Saved in:
  6. 86
    Time to onset of AEs in male and female patients receiving finasteride therapy.

    Time to onset of AEs in male and female patients receiving finasteride therapy. by Xiaoling Zhong (181270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 87
    Characteristics of patients with AKI diagnosed using KDIGO definition versus patients diagnosed with AKI by eKDIGO only by the decrease in sCr (deKDIGO).

    Characteristics of patients with AKI diagnosed using KDIGO definition versus patients diagnosed with AKI by eKDIGO only by the decrease in sCr (deKDIGO). by Marina Wainstein (12437091)

    Published 2022
    Save to List
    Saved in:
  8. 88
    Experimental apparatus and visual display.

    Experimental apparatus and visual display. by David Apreutesei (19429483)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 89
    Timeline of reaching trials.

    Timeline of reaching trials. by David Apreutesei (19429483)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 90
    Correlational analyses of explicit and implicit adaptation relative to mental fatigue.

    Correlational analyses of explicit and implicit adaptation relative to mental fatigue. by David Apreutesei (19429483)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 91
    Self-reported health outcomes baseline and 12-week comparisons.

    Self-reported health outcomes baseline and 12-week comparisons. by Christopher Angelillo (17743121)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 92
    Relish SUMOylation decreases its transcriptional activity.

    Relish SUMOylation decreases its transcriptional activity. by Ruijuan Tang (11250680)

    Published 2021
    Save to List
    Saved in:
  13. 93
    Burials <i>in situ</i> at the cemetery in Wtórek, Greater Poland, Poland.

    Burials <i>in situ</i> at the cemetery in Wtórek, Greater Poland, Poland. by Agata Hałuszko (13608045)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 94
    Data for the G7 countries in 2022.

    Data for the G7 countries in 2022. by Luis Alberiko Gil-Alana (14659817)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 95
    Basic information and patient characteristics according to the report.

    Basic information and patient characteristics according to the report. by Xiaoling Zhong (181270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 96
    Supplementary Material for: Decrease in mycophenolic acid plasma level by sacubitril/valsartan in lupus nephritis patient: a case report

    Supplementary Material for: Decrease in mycophenolic acid plasma level by sacubitril/valsartan in lupus nephritis patient: a case report by Nashimoto S. (17866511)

    Published 2024
    “…Mycophenolate mofetil (MMF), an inactive prodrug of mycophenolic acid (MPA), is an immunosuppressive drug used widely in the treatment of lupus nephritis. In this case report, the area under the blood concentration time curve (AUC) of MPA was significantly decreased by the concomitant use of sacubitril/valsartan. …”
    Save to List
    Saved in:
  17. 97
    Transepithelial resistance of NHBE decreases significantly after PAA exposure.

    Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

    Published 2025
    Save to List
    Saved in:
  18. 98
    Effects of menthol and Akt inhibitors on the gene expression of MRP2.

    Effects of menthol and Akt inhibitors on the gene expression of MRP2. by Katsuhito Nagai (11668793)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 99
    Effects of menthol on cytotoxicity of EPI and CIS.

    Effects of menthol on cytotoxicity of EPI and CIS. by Katsuhito Nagai (11668793)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  20. 100
    Effect of menthol on intracellular accumulation and efflux of EPI.

    Effect of menthol on intracellular accumulation and efflux of EPI. by Katsuhito Nagai (11668793)

    Published 2023
    Subjects:
    Save to List
    Saved in:

Search Tools: